Subscribe to our mailing list

* indicates required

Friday, February 22, 2013

Eli Lilly and its Zyprexa Go-to-Market B.S.

Eli Lilly Sales Organization backgrounder.

Weight gain and diabetes are among the small-print risks for all major atypical antipsychotic medications now. But not all atypicals are equal. What patients knew intuitively is now established scientifically: Lilly's Zyprexa produces the worst weight gain of all of the major atypicals. You don't have to dig through the medical literature to find out how bad the situation is. Just ask a friend. Or if you don't have any friends on Zyprexa, go online to the health forums, or to YouTube, where you won't have any trouble locating people who've gained 25% or more in body weight from taking Zyprexa.

Just for fun, you might want to hear how these drugs are sold to doctors. The  video below is by a guy who sold Zyprexa for a living. Have a listen. The spin job begins with Corporate, funnels down through Sales, reaches your doctor, and ends with (guess who?) you.

1 comment:

  1. The Eli Lilly Zyprexa saga,a criminal conspiracy from the get-go
    Eli Lilly has made $70 billion on Zyprexa (Olanzapine) and it was way oversold and caused diabetes and in some cases sudden death.
    Still making $1.5 billion year on the Zyprexa franchise.
    Eight Lilly employees who are supposed ‘whistleblowers’ got $10 million each payouts, the real victims like me were ignored. Law firms on both sides of the aisle made tens of millions.
    I am a living example of Zyprexa gone/done wrong was given it 1996-2000 off-label for PTSD got sudden high blood sugar A1C 14.7 in January 2000.The stuff was worthless for my condition PTSD and cost me thousands in co-pays gave me diabetes.

    Daniel Haszard


Add a comment. Registration required because trolls.